Meet the
Expert Session
Want to learn more about our RESILIA valves portfolio?
We invite you to attend our live presentations at the booth with experts sharing their experiences with INSPIRIS and MITRIS RESILIA valves.
Thursday 10 Oct 2024
MITRIS RESILIA valve:The Latest Mitral Surgical Innovation
A Patient Story: Double Valve Replacement with INSPIRIS and MITRIS RESILIA valves
Friday 11 Oct 2024
Minimally Invasive Surgery with the INSPIRIS RESILIA valve
MITRIS RESILIA valve:The Latest Mitral Surgical Innovation
Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.
Reference: Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791.
Expert opinions, advice and all other information represent contributor’s views and not necessarily those of Edwards Lifesciences.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).